Novartis logo
Novartis
NVSEF | OTC
Chart Builder DCF Calculator
$134.20
-$6.73 (-4.78%)
At close: Oct 2, 2026, 3:14 PM ET

Novartis Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
Q4 2020
Dec 31, 2020
Q3 2020
Sep 30, 2020
Q2 2020
Jun 30, 2020
Q1 2020
Mar 31, 2020
4.02B 3.61B 2.82B 3.26B 3.27B 2.61B 2.64B 1.51B 2.32B 2.29B 1.47B 1.58B 1.7B 2.22B 16.31B 2.76B 2.9B 2.06B 2.1B 1.93B 1.87B 2.17B
1.26B 1.15B 1.63B 2.01B 1.17B 1.27B 1.59B 3.11B 1.83B 2B 1.95B 2.03B 1.8B 1.41B 1.52B 1.45B 1.44B 1.7B 1.62B 1.73B 1.7B 1.41B
267M 262M 272M 255M 257M 260M 248M 205M 222M 190M 197M 219M 204M 203M 195M 173M 185M 183M 159M 202M 199M 178M
796M -617.43M -543M 723.94M 589.73M -848.07M -741M 1.51B 512M -121M -51M 920M -54M -2.01B 1.18B 409M 130M -1.47B 1.22B -36M 650M -2.13B
168M -382.58M -997M -478.7M 3.53B 4.54B -1.28B -668M -1.09B -474M -360M 80M -239M -617M -15.96B -340M -1.13B -726M -1.55B -1.15B -879M 446M
507M 798M 465M 200M 595M 441M -261M 39M 452M 446M 275M 344M 347M 450M 645M 472M 611M 391M 460M 478M 421M 448M
442M -1.8B 5M 1.04B -89.17M -2.26B -384M 1.18B -162M -1.5B 585M 477M -54M -2.01B 1.18B 409M 130M -1.47B 1.22B -36M 650M -2.13B
6.66B 3.65B 4.19B 6.29B 4.86B 2.2B 2.55B 5.38B 3.58B 2.96B 4.11B 4.72B 3.76B 1.65B 3.88B 4.93B 4.13B 2.13B 4.01B 3.16B 3.96B 2.53B
-558M -254M -1.13B -799M -740.08M -1.12B -783M -683M -996M -470M -647M -582M -583M -859M -977M -539M -597M -858M -1.02B -627M -452M -480M
-1.68B -7M -264M -12.1M -3.25B -269.44M -11M -3.45B -86M -42M -11M 8M -61M -839M 20.33B -17M -2M -211M 53M -112M -2M -9.9B
-58M -55M -2.31B -1.01B -279.91M -48.46M -573M -39M -31M -107M -10.58B -6.71B -13.27B -4.26B -15.63B -807M -87M -86M -160M -1.54B -112M -323M
50M 1.91B 581M 1.51B 1.06B 566.99M 179M 290M 50M 11.08B 9.66B 12.46B 2.15B 15.22B 689M 22M 246M 1.8B 308M 154M 189M 564M
-226M 4.08M -487M -538.24M 19.79M -431M -572M 1.67B 10M 162M 108M 21M 140M 99M -364M -79M 261M -480M -251M -273M -262M -245M
-2.24B 330M -3.03B -374M -3.19B -871.33M -1.76B -2.21B -1.05B 10.62B -1.47B 5.2B -11.63B 9.37B 4.56B -1.23B 97M 780M -571M -2.05B -425M -10.14B
181M -461.04M -106M 2.51B 833M 1.15B 610M -2.29B -737.17M 933M -1.25B -1.87B – 404M -738M -1.15B -78M 755M -96M 2.82B -2.25B 7.53B
-2.71B -2.72B -2.76B -2.85B -1.62B -1.1B -1.25B -1.63B -2.96B -2.89B -2.68B -2.72B -2.71B -2.54B -148M -284M -703M -1.92B -1.77B -924M -9M -141M
-2.49B -5.33B -4.14M 85.3M -2.48B -5.05B -57.58M -53.24M -106.72M -7.33B -50.99M -32.23M -162.43M -7.51B -39.93M -8.45M -17.62M -7.37B – – – -6.99B
-195M 3.14M -123.86M -48.31M -22.9M -205.11M 34M 3.08B 57.17M 6M 122.94M -118.32M 574.43M 116M -2.37B -96M -2.16B -5M -1.07B 8M 69M 609M
-5.21B -8.55B -3B -382M -3.25B -5.01B -607M -832M -3.64B -9.2B -3.99B -4.74B -2.3B -9.53B -3.25B -1.53B -2.94B -8.54B -2.94B 1.9B -2.19B 1.01B
-410M -4.39B -2.15B 5.71B -1.55B -3.93B 988M 1.52B -1.12B 4.48B -1.21B 5.1B -10.23B 1.45B 5.2B 2.09B 1.32B -5.86B 664M 3.08B 1.39B -6.58B
6.11B 3.39B 3.06B 5.49B 4.12B 1.07B 1.76B 4.7B 2.58B 2.49B 3.46B 4.14B 3.17B 790M 2.91B 4.39B 3.54B 1.27B 2.98B 2.53B 3.51B 2.05B
5.84B 3.13B 2.79B 5.23B 3.87B 814.86M 1.52B 4.49B 2.36B 2.3B 3.27B 3.92B 2.97B 587M 2.71B 4.21B 3.35B 1.09B 2.82B 2.33B 3.31B 1.87B
-558M -254M -676.71M -523.68M -740.08M -1.12B -783M -683M -764.55M -362.84M -647M -582M -583M -825.03M -831.89M -294.5M -103.88M -858M -928.05M -610.07M -452M -101.09M
– – -454.29M -275.32M – – – – -231.45M -107.16M – – – -33.97M -145.11M -244.5M -493.12M – -94.95M -16.93M – -378.91M
6.11B 3.39B 3.52B 5.76B 4.12B 1.07B 1.76B 4.7B 2.81B 2.59B 3.46B 4.14B 3.17B 823.97M 3.05B 4.63B 4.03B 1.27B 3.08B 2.55B 3.51B 2.43B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.